nach oben

Current Urology Reports

Erschienen in:

01.06.2012 | Endourology (V Bird, Section editor)

The Role of Minimally Invasive Surgery in Multifocal Renal Cell Carcinoma

verfasst von: Serge Ginzburg, Robert G. Uzzo, Alexander Kutikov

Erschienen in: Current Urology Reports | Ausgabe 3/2012

Einloggen, um Zugang zu erhalten

Abstract

Surgical excision remains the reference standard for treatment of localized renal cell carcinoma (RCC). Laparoscopic and robotic minimally invasive extirpative approaches are being increasingly employed in current urologic practice. Multiple tumors in the same kidney present a unique set of challenges for minimally invasive surgeons. As such, we review recent literature regarding minimally invasive nephron-sparing surgery in patients with synchronous, ipsilateral, multifocal renal tumors. As the experience with these complex operations grows, perioperative, short-term functional and oncologic outcomes appear comparable to traditional open nephron-sparing surgery. Data on surgical approaches to patients with synchronous, ipsilateral, multifocal RCC are emerging. Short-term results suggest minimally invasive nephron-sparing surgery is safe, feasible, and should be considered as a potential treatment option for patients who present with multiple tumors in the same renal unit.

Simard EP, Ward EM, Siegel R, Jemal A: Cancers with increasing incidence trends in the united states: 1999 through 2008. CA: a cancer journal for clinicians 2012.

Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA: a cancer journal for clinicians. 2012;62:10–29.CrossRef

Hollingsworth JM, Miller DC, Daignault S, Hollenbeck BK. Rising incidence of small renal masses: a need to reassess treatment effect. J Natl Cancer Inst. 2006;98:1331–4.PubMedCrossRef

Cooperberg MR, Mallin K, Ritchey J, Villalta JD, Carroll PR, Kane CJ. Decreasing size at diagnosis of stage 1 renal cell carcinoma: analysis from the national cancer data base, 1993 to 2004. J Urol. 2008;179:2131–5.PubMedCrossRef

Campbell SC, Novick AC, Belldegrun A, Blute ML, Chow GK, Derweesh IH, Faraday MM, Kaouk JH, Leveillee RJ, Matin SF, Russo P, Uzzo RG. Guideline for management of the clinical t1 renal mass. J Urol. 2009;182:1271–9.PubMedCrossRef

Kutikov A, Fossett LK, Ramchandani P, Tomaszewski JE, Siegelman ES, Banner MP, Van Arsdalen KN, Wein AJ, Malkowicz SB. Incidence of benign pathologic findings at partial nephrectomy for solitary renal mass presumed to be renal cell carcinoma on preoperative imaging. Urology. 2006;68:737–40.PubMedCrossRef

Kutikov A, Egleston BL, Wong YN, Uzzo RG. Evaluating overall survival and competing risks of death in patients with localized renal cell carcinoma using a comprehensive nomogram. J Clin Oncol. 2010;28:311–7.PubMedCrossRef

Kutikov A, Smaldone MC, Egleston BL, Manley BJ, Canter DJ, Simhan J, Boorjian SA, Viterbo R, Chen DY, Greenberg RE, Uzzo RG. Anatomic features of enhancing renal masses predict malignant and high-grade pathology: a preoperative nomogram using the renal nephrometry score. Eur Urol. 2011;60:241–8.PubMedCrossRef

Smaldone M. Assessing performance trends in laparoscopic nephrectomy and nephron sparing surgery for localized renal tumors. Urology 2012.

10.

Patel SG, Penson DF, Pabla B, Clark PE, Cookson MS, Chang SS, Herrell SD, Smith Jr JA, et al. National trends in the use of partial nephrectomy: a rising tide that has not lifted all boats. J Urol. 2012;187:816–21.PubMedCrossRef

11.

Smaldone MC, Kutikov A, Egleston BL, Canter DJ, Viterbo R, Chen DY, Jewett MA, Greenberg RE, Uzzo RG. Small renal masses progressing to metastases under active surveillance: a systematic review and pooled analysis. Cancer. 2012;118:997–1006.PubMedCrossRef

12.

Crispen PL, Viterbo R, Boorjian SA, Greenberg RE, Chen DYT, Uzzo RG. Natural history, growth kinetics, and outcomes of untreated clinically localized renal tumors under active surveillance. Cancer. 2009;115:2844–52.PubMedCrossRef

13.

Scoll BJ, Uzzo RG, Chen DY, Boorjian SA, Kutikov A, Manley BJ, Viterbo R. Robot-assisted partial nephrectomy: a large single-institutional experience. Urology. 2010;75:1328–34.PubMedCrossRef

14.

Long CJ, Canter DJ, Kutikov A, Li T, Simhan J, Smaldone M, et al. Partial nephrectomy for renal masses >/=7 cm: technical, oncological and functional outcomes. BJU Int 2012.

15.

Simhan JSM, Tsai KJ, Canter D, Li T, Kutikov A, Chen DYT, et al. Perioperative outcomes of robotic and open partial nephrectomy for moderate and high complexity renal lesions. J Urol 2012;in press.

16.

Bratslavsky G. Argument in favor of performing partial nephrectomy for tumors greater than 7 cm: the metastatic prescription has already been written. Urol Oncol. 2011;29:829–32.PubMedCrossRef

17.

• Boris R, Proano M, Linehan WM, Pinto PA, Bratslavsky G. Initial experience with robot assisted partial nephrectomy for multiple renal masses. J Urol 2009;182:1280–1286. The authors report a retrospective case series of 10 patients with attempted RPN, in a predominantly (70%) hereditary multifocal RCC cohort. One conversion from RPN to OPN was observed. Short-term functional outcomes were described, and a single complication, a urinary leak requiring continuous drainage for 9 days, was reported.

18.

Wells S. Successful removal of two solid circum renal tumours. British Medical Journal. 1884;1:758.PubMedCrossRef

19.

Uzzo RG, Novick AC. Nephron sparing surgery for renal tumors: indications, techniques and outcomes. J Urol. 2001;166:6–18.PubMedCrossRef

20.

Robson CJ, Churchill BM, Anderson W. The results of radical nephrectomy for renal cell carcinoma. J Urol. 1969;101:297–301.PubMed

21.

Campbell SC, Novick AC, Streem SB, Klein E, Licht M. Complications of nephron sparing surgery for renal tumors. J Urol. 1994;151:1177–80.PubMed

22.

Lerner SE, Hawkins CA, Blute ML, Grabner A, Wollan PC, Eickholt JT, Zincke H. Disease outcome in patients with low stage renal cell carcinoma treated with nephron sparing or radical surgery. J Urol. 1996;155:1868–73.PubMedCrossRef

23.

Belldegrun A, Tsui KH, de Kernion JB, Smith RB. Efficacy of nephron-sparing surgery for renal cell carcinoma: analysis based on the new 1997 tumor-node-metastasis staging system. J Clin Oncol. 1999;17:2868–75.PubMed

24.

Ljungberg B, Cowan NC, Hanbury DC, Hora M, Kuczyk MA, Merseburger AS, Patard JJ, Mulders PF, Sinescu IC. Eau guidelines on renal cell carcinoma: the 2010 update. Eur Urol. 2010;58:398–406.PubMedCrossRef

25.

Winfield HN, Donovan JF, Godet AS, Clayman RV. Laparoscopic partial nephrectomy: initial case report for benign disease. Journal of Endourology/Endourological Society. 1993;7:521–6.PubMedCrossRef

26.

Aron M, Gill IS. Minimally invasive nephron-sparing surgery (minss) for renal tumours part i: Laparoscopic partial nephrectomy. European Urology 2007;51:337–346; discussion 346–337.

27.

Gettman MT, Blute ML, Chow GK, Neururer R, Bartsch G, Peschel R. Robotic-assisted laparoscopic partial nephrectomy: technique and initial clinical experience with davinci robotic system. Urology. 2004;64:914–8.PubMedCrossRef

28.

Spana G, Haber GP, Dulabon LM, Petros F, Rogers CG, Bhayani SB, Stifelman MD, Kaouk JH. Complications after robotic partial nephrectomy at centers of excellence: multi-institutional analysis of 450 cases. J Urol. 2011;186:417–21.PubMedCrossRef

29.

Benway BM, Bhayani SB, Rogers CG, Porter JR, Buffi NM, Figenshau RS, Mottrie A. Robot-assisted partial nephrectomy: an international experience. Eur Urol. 2010;57:815–20.PubMedCrossRef

30.

Reyes JM, Smaldone MC, Uzzo RG, Viterbo R. Current status of robot-assisted partial nephrectomy. Current Urology Reports. 2012;13:24–37.PubMedCrossRef

31.

Patel MN, Bhandari M, Menon M, Rogers CG. Robotic-assisted partial nephrectomy. BJU Int. 2009;103:1296–311.PubMedCrossRef

32.

Weizer AZ, Gilbert SM, Roberts WW, Hollenbeck BK, Wolf Jr JS. Tailoring technique of laparoscopic partial nephrectomy to tumor characteristics. J Urol. 2008;180:1273–8.PubMedCrossRef

33.

Corcoran AT, Hayn MH, Gibbons EP, Mori R, Hrebinko R, Davies BJ. Partial nephrectomy without hilar control or cooling: longitudinal data over 5 years. Can J Urol. 2009;16:4820–5.PubMed

34.

Lane BR, Tiong HY, Campbell SC, Fergany AF, Weight CJ, Larson BT, et al. Management of the adrenal gland during partial nephrectomy. J Urol. 2009;181:2430–2436; discussion 2436–2437.

35.

Weight CJ, Kim SP, Lohse CM, Cheville JC, Thompson RH, Boorjian SA, Leibovich BC. Routine adrenalectomy in patients with locally advanced renal cell cancer does not offer oncologic benefit and places a significant portion of patients at risk for an asynchronous metastasis in a solitary adrenal gland. Eur Urol. 2011;60:458–64.PubMedCrossRef

36.

Kutikov A, Piotrowski ZJ, Canter DJ, Li T, Chen DY, Viterbo R, Greenberg RE, Boorjian SA, Uzzo RG. Routine adrenalectomy is unnecessary during surgery for large and/or upper pole renal tumors when the adrenal gland is radiographically normal. J Urol. 2011;185:1198–203.PubMedCrossRef

37.

Novick AC. Renal hypothermia: in vivo and ex vivo. Urol Clin N Am. 1983;10:637–44.

38.

Bhayani SB, Rha KH, Pinto PA, Ong AM, Allaf ME, Trock BJ, Jarrett TW, Kavoussi LR. Laparoscopic partial nephrectomy: effect of warm ischemia on serum creatinine. J Urol. 2004;172:1264–6.PubMedCrossRef

39.

Lane BR, Gill IS, Fergany AF, Larson BT, Campbell SC. Limited warm ischemia during elective partial nephrectomy has only a marginal impact on renal functional outcomes. J Urol. 2011;185:1598–603.PubMedCrossRef

40.

Simmons MN, Fergany AF, Campbell SC. Effect of parenchymal volume preservation on kidney function after partial nephrectomy. J Urol 2011.

41.

Sharma N, O'Hara J, Novick AC, Lieber M, Remer EM, Herts BR. Correlation between loss of renal function and loss of renal volume after partial nephrectomy for tumor in a solitary kidney. J Urol. 2008;179:1284–8.PubMedCrossRef

42.

Sorbellini M, Kattan MW, Snyder ME, Hakimi AA, Sarasohn DM, Russo P. Prognostic nomogram for renal insufficiency after radical or partial nephrectomy. J Urol 2006;176:472–6; discussion 476.

43.

Canter D, Kutikov A, Manley B, Egleston B, Simhan J, Smaldone M, et al. Utility of the r.E.N.A.L. Nephrometry scoring system in objectifying treatment decision-making of the enhancing renal mass. Urology 2011;78:1089–94.

44.

Ficarra V, Novara G, Secco S, Macchi V, Porzionato A, De Caro R, Artibani W. Preoperative aspects and dimensions used for an anatomical (padua) classification of renal tumours in patients who are candidates for nephron-sparing surgery. Eur Urol. 2009;56:786–93.PubMedCrossRef

45.

Simmons MN, Ching CB, Samplaski MK, Park CH, Gill IS. Kidney tumor location measurement using the c index method. J Urol. 2010;183:1708–13.PubMedCrossRef

46.

Kutikov A, Uzzo RG. The r.E.N.A.L. Nephrometry score: a comprehensive standardized system for quantitating renal tumor size, location and depth. J Urol. 2009;182:844–53.PubMedCrossRef

47.

Montag S, Waingankar N, Sadek MA, Rais-Bahrami S, Kavoussi LR, Vira MA. Reproducibility and fidelity of the r.E.N.A.L. Nephrometry score. J Endourol. 2011;25:1925–8.PubMedCrossRef

48.

Weight CJ, Atwell TD, Fazzio RT, Kim SP, Kenny M, Lohse CM, Boorjian SA, Leibovich BC, Thompson RH. A multidisciplinary evaluation of inter-reviewer agreement of the nephrometry score and the prediction of long-term outcomes. J Urol. 2011;186:1223–8.PubMedCrossRef

49.

Minervini A, Ficarra V, Rocco F, Antonelli A, Bertini R, Carmignani G, et al. Simple enucleation is equivalent to traditional partial nephrectomy for renal cell carcinoma: results of a nonrandomized, retrospective, comparative study. J Urol. 2011;185:1604–10.PubMedCrossRef

50.

Bratslavsky G, Linehan WM. Long-term management of bilateral, multifocal, recurrent renal carcinoma. Nature Reviews Urology. 2010;7:267–75.PubMedCrossRef

51.

Simhan J, Smaldone MC, Tsai KJ, Canter DJ, Li T, Kutikov A, Viterbo R, Chen DY, Greenberg RE, Uzzo RG. Objective measures of renal mass anatomic complexity predict rates of major complications following partial nephrectomy. Eur Urol. 2011;60:724–30.PubMedCrossRef

52.

Benway BM, Wang AJ, Cabello JM, Bhayani SB. Robotic partial nephrectomy with sliding-clip renorrhaphy: technique and outcomes. Eur Urol. 2009;55:592–9.PubMedCrossRef

53.

Sammon J, Petros F, Sukumar S, Bhandari A, Kaul S, Menon M, Rogers C. Barbed suture for renorrhaphy during robot-assisted partial nephrectomy. J Endourol. 2011;25:529–33.PubMedCrossRef

54.

Marszalek M, Carini M, Chlosta P, Jeschke K, Kirkali Z, Knuchel R, et al. Positive surgical margins after nephron-sparing surgery. European Urology 2011.

55.

Saranchuk JW, Touijer AK, Hakimian P, Snyder ME, Russo P. Partial nephrectomy for patients with a solitary kidney: the memorial sloan-kettering experience. BJU Int. 2004;94:1323–8.PubMedCrossRef

56.

Yossepowitch O, Thompson RH, Leibovich BC, Eggener SE, Pettus JA, Kwon ED, Herr HW, Blute ML, Russo P. Positive surgical margins at partial nephrectomy: predictors and oncological outcomes. J Urol. 2008;179:2158–63.PubMedCrossRef

57.

Raz O, Mendlovic S, Shilo Y, Leibovici D, Sandbank J, Lindner A, Zisman A. Positive surgical margins with renal cell carcinoma have a limited influence on long-term oncological outcomes of nephron sparing surgery. Urology. 2010;75:277–80.PubMedCrossRef

58.

Kutikov A, Vanarsdalen KN, Gershman B, Fossett LK, Guzzo TJ, Wein AJ, Malkowicz SB. Enucleation of renal cell carcinoma with ablation of the tumour base. BJU Int. 2008;102:688–91.PubMedCrossRef

59.

Minervini A, Serni S, Tuccio A, Raspollini MR, Di Cristofano C, Siena G, et al. Local recurrence after tumour enucleation for renal cell carcinoma with no ablation of the tumour bed: results of a prospective single-centre study. BJU Int 2011:no-no.

60.

Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004;351:1296–305.PubMedCrossRef

61.

Thompson RH, Boorjian SA, Lohse CM, Leibovich BC, Kwon ED, Cheville JC, et al. Radical nephrectomy for pt1a renal masses may be associated with decreased overall survival compared with partial nephrectomy. The Journal of Urology 2008;179:468–71; discussion 472–463.

62.

Weight CJ, Larson BT, Fergany AF, Gao T, Lane BR, Campbell SC, Kaouk JH, Klein EA, Novick AC. Nephrectomy induced chronic renal insufficiency is associated with increased risk of cardiovascular death and death from any cause in patients with localized ct1b renal masses. J Urol. 2010;183:1317–23.PubMedCrossRef

63.

Huang WC, Elkin EB, Levey AS, Jang TL, Russo P. Partial nephrectomy versus radical nephrectomy in patients with small renal tumors—is there a difference in mortality and cardiovascular outcomes? The Journal of Urology 2009;181:55–61; discussion 61–52.

64.

Lane BR, Fergany AF, Linehan WM, Bratslavsky G. Should preservable parenchyma, and not tumor size, be the main determinant of the feasibility of partial nephrectomy? Urology. 2010;76:608–9.PubMedCrossRef

65.

Breau RH, Crispen PL, Jimenez RE, Lohse CM, Blute ML, Leibovich BC. Outcome of stage t2 or greater renal cell cancer treated with partial nephrectomy. J Urol. 2010;183:903–8.PubMedCrossRef

66.

Woldu SL, Barlow LJ, Patel T, Hruby GW, Benson MC, McKiernan JM. Single institutional experience with nephron-sparing surgery for pathologic stage t3bnxm0 renal cell carcinoma confined to the renal vein. Urology. 2010;76:639–42.PubMedCrossRef

67.

Gupta GN, Peterson J, Thakore KN, Pinto PA, Linehan WM, Bratslavsky G. Oncological outcomes of partial nephrectomy for multifocal renal cell carcinoma greater than 4 cm. J Urol. 2010;184:59–63.PubMedCrossRef

68.

Lebed B, Jani SD, Kutikov A, Iffrig K, Uzzo RG. Renal masses herniating into the hilum: technical considerations of the "ball-valve phenomenon" during nephron-sparing surgery. Urology. 2010;75:707–10.PubMedCrossRef

69.

• Lane BR, Russo P, Uzzo RG, Hernandez AV, Boorjian SA, Thompson RH, et al. Comparison of cold and warm ischemia during partial nephrectomy in 660 solitary kidneys reveals predominant role of nonmodifiable factors in determining ultimate renal function. The Journal of Urology 2011;185:421–7. This large retrospective multi-institutional cohort of 660 solitary renal units undergoing NSS using cold (n = 300) and warm (n = 360) ischemia demonstrated that median eGFR decrease was similar between the two groups (21% vs 22%), despite having different ischemia times (45 vs 22 minutes). On multivariate analysis, ischemia time lost statistical significance, while preoperative eGFR and percentage of preserved parenchyma were strongest predictors of ultimate renal function.

70.

Fadahunsi AT, Sanford T, Linehan WM, Pinto PA, Bratslavsky G. Feasibility and outcomes of partial nephrectomy for resection of at least 20 tumors in a single renal unit. J Urol. 2011;185:49–53.PubMedCrossRef

71.

Canter D, Kutikov A, Sirohi M, Street R, Viterbo R, Chen DY, Greenberg RE, Uzzo RG. Prevalence of baseline chronic kidney disease in patients presenting with solid renal tumors. Urology. 2011;77:781–5.PubMedCrossRef

72.

Huang WC, Levey AS, Serio AM, Snyder M, Vickers AJ, Raj GV, Scardino PT, Russo P. Chronic kidney disease after nephrectomy in patients with renal cortical tumours: a retrospective cohort study. Lancet Oncol. 2006;7:735–40.PubMedCrossRef

73.

Stief CG: If a partial nephrectomy could be done safely for a renal tumor, would radical nephrectomy be considered malpractice? Eur Urol 2011;60:465–6; discussion 466–7.

74.

Kutikov A, Smaldone MC, Egleston BL, Uzzo RG. Should partial nephrectomy be offered to all patients whenever technically feasible? Eur Urol 2011.

75.

Finley DS, Pantuck AJ, Belldegrun AS. Tumor biology and prognostic factors in renal cell carcinoma. Oncologist. 2011;16 Suppl 2:4–13.PubMedCrossRef

76.

Klatte T, Wunderlich H, Patard JJ, Kleid MD, Lam JS, Junker K, Schubert J, Bohm M, Allhoff EP, Kabbinavar FF, Crepel M, Cindolo L, De La Taille A, Tostain J, Mejean A, Soulie M, Bellec L, Bernhard JC, Ferriere JM, Pfister C, Albouy B, Colombel M, Zisman A, Belldegrun AS, Pantuck AJ. Clinicopathological features and prognosis of synchronous bilateral renal cell carcinoma: an international multicentre experience. BJU Int. 2007;100:21–5.PubMedCrossRef

77.

Cheville JC, Lohse CM, Zincke H, Weaver AL, Blute ML. Comparisons of outcome and prognostic features among histologic subtypes of renal cell carcinoma. Am J Surg Pathol. 2003;27:612–24.PubMedCrossRef

78.

Dimarco DS, Lohse CM, Zincke H, Cheville JC, Blute ML. Long-term survival of patients with unilateral sporadic multifocal renal cell carcinoma according to histologic subtype compared with patients with solitary tumors after radical nephrectomy. Urology. 2004;64:462–7.PubMedCrossRef

79.

Waldert M, Haitel A, Marberger M, Katzenbeisser D, Ozsoy M, Stadler E, Remzi M. Comparison of type i and ii papillary renal cell carcinoma (rcc) and clear cell rcc. BJU Int. 2008;102:1381–4.PubMed

80.

Walther MM, Lubensky IA, Venzon D, Zbar B, Linehan WM. Prevalence of microscopic lesions in grossly normal renal parenchyma from patients with von hippel-lindau disease, sporadic renal cell carcinoma and no renal disease: clinical implications. The Journal of Urology 1995;154:2010–4; discussion 2014–2015.

81.

Ornstein DK, Lubensky IA, Venzon D, Zbar B, Linehan WM, Walther MM. Prevalence of microscopic tumors in normal appearing renal parenchyma of patients with hereditary papillary renal cancer. J Urol. 2000;163:431–3.PubMedCrossRef

82.

Steinbach F, Novick AC, Zincke H, Miller DP, Williams RD, Lund G, Skinner DG, Esrig D, Richie JP, et al. Treatment of renal cell carcinoma in von hippel-lindau disease: a multicenter study. J Urol. 1995;153:1812–6.PubMedCrossRef

83.

Herring JC, Enquist EG, Chernoff A, Linehan WM, Choyke PL, Walther MM. Parenchymal sparing surgery in patients with hereditary renal cell carcinoma: 10-year experience. J Urol. 2001;165:777–81.PubMedCrossRef

84.

Whang M, O'Toole K, Bixon R, Brunetti J, Ikeguchi E, Olsson CA, Sawczuk TS, Benson MC. The incidence of multifocal renal cell carcinoma in patients who are candidates for partial nephrectomy. The Journal of Urology 1995;154:968–70; discussion 970–961.

85.

Richstone L, Scherr DS, Reuter VR, Snyder ME, Rabbani F, Kattan MW, Russo P. Multifocal renal cortical tumors: frequency, associated clinicopathological features and impact on survival. J Urol. 2004;171:615–20.PubMedCrossRef

86.

Tsivian M, Moreira DM, Caso JR, Mouraviev V, Madden JF, Bratslavsky G, Robertson CN, Albala DM, Polascik TJ. Predicting occult multifocality of renal cell carcinoma. Eur Urol. 2010;58:118–26.PubMedCrossRef

87.

Kirkali Z. Editorial comment on: predicting occult multifocality of renal cell carcinoma. Eur Urol. 2010;58:126.PubMedCrossRef

88.

Blute ML, Amling CL, Bryant SC, Zincke H. Management and extended outcome of patients with synchronous bilateral solid renal neoplasms in the absence of von hippel-lindau disease. Mayo Clinic Proceedings Mayo Clinic. 2000;75:1020–6.PubMedCrossRef

89.

Rothman J, Crispen PL, Wong YN, Al-Saleem T, Fox E, Uzzo RG. Pathologic concordance of sporadic synchronous bilateral renal masses. Urology. 2008;72:138–42.PubMedCrossRef

90.

Krambeck A, Iwaszko M, Leibovich B, Cheville J, Frank I, Blute M. Long-term outcome of multiple ipsilateral renal tumours found at the time of planned nephron-sparing surgery. BJU Int. 2008;101:1375–9.PubMedCrossRef

91.

Simhan J CD, Smaldone MC, Tsai KJ, Li T, Viterbo R, Chen DYT, et al. Pathologic concordance and operative outcomes of sporadic synchronous unilateral multifocal renal masses. in press 2012.

92.

Junker K, Thrum K, Schlichter A, Muller G, Hindermann W, Schubert J. Clonal origin of multifocal renal cell carcinoma as determined by microsatellite analysis. J Urol. 2002;168:2632–6.PubMedCrossRef

93.

Lang H, Lindner V, Martin M, Letourneux H, Roy C, Saussine C, Jacqmin D. Prognostic value of multifocality on progression and survival in localized renal cell carcinoma. Eur Urol. 2004;45:749–53.PubMedCrossRef

94.

Leibovich BC, Blute ML, Cheville JC, Lohse CM, Frank I, Kwon ED, Weaver AL, Parker AS, Zincke H. Prediction of progression after radical nephrectomy for patients with clear cell renal cell carcinoma: a stratification tool for prospective clinical trials. Cancer. 2003;97:1663–71.PubMedCrossRef

95.

Licht MR, Novick AC, Goormastic M. Nephron sparing surgery in incidental versus suspected renal cell carcinoma. J Urol. 1994;152:39–42.PubMed

96.

Lin YC, Turna B, Frota R, Aron M, Haber GP, Kamoi K, Koenig P, Gill IS. Laparoscopic partial nephrectomy versus laparoscopic cryoablation for multiple ipsilateral renal tumors. Eur Urol. 2008;53:1210–6.PubMedCrossRef

97.

Steinberg AP, Kilciler M, Abreu SC, Ramani AP, Ng C, Desai MM, Kaouk JH, Gill IS. Laparoscopic nephron-sparing surgery for two or more ipsilateral renal tumors. Urology. 2004;64:255–8.PubMedCrossRef

98.

• Flum AS, Wolf JS, Jr.: Laparoscopic partial nephrectomy for multiple ipsilateral renal tumors using a tailored surgical approach. Journal of Endourology/Endourological Society 2010;24:557–61. This was a cohort of seven patients (16 tumors), four with imperative indications. Four patients were treated with off-clamp LPN. In the clamp group, one positive surgical margin and one intraoperative hemorrhage requiring blood transfusion were noted. At 48 months, no tumor recurrence or progression to metastatic disease was noted. Systematic approach is described based on location (anterior vs posterior), depth of penetration (< 5 mm vs > 5 mm), and proximity to collecting system (entry vs no entry) determining the approach (transperitoneal vs retroperitoneoscopic), ischemia (off-clamp vs clamp), and renal bed control (sutured bolster vs coagulation/hemostatic agents).

99.

• Laydner H, Autorino R, Spana G, Altunrende F, Yang B, Khanna R, et al. Robot-assisted partial nephrectomy for sporadic ipsilateral multifocal renal tumours. BJU international 2012;109:274–80. In this study, eight patients underwent nine RPNs for 19 tumors (84% malignant). Lesion characteristics were objectified (R.E.N.A.L. Nephrometry and PADUA scores) and reporting of complications was used using a standardized metric (Clavien). Intermediate complexity (37%) and low complexity (63%) lesions were treated and perioperative outcomes were reported.

100.

Rogers CG, Singh A, Blatt AM, Linehan WM, Pinto PA. Robotic partial nephrectomy for complex renal tumors: surgical technique. Eur Urol. 2008;53:514–21.PubMedCrossRef

101.

• Tsivian A, Tsivian M, Benjamin S, Sidi AA. Laparoscopic partial nephrectomy for multiple tumours: feasibility and analysis of peri-operative outcomes. BJU Int 2011;108:1330–1334. This was a single-institution cohort (n = 12) of multifocal ipsilateral renal tumors is compared to a larger cohort (n = 99) of sporadic solitary renal tumors, both managed with LPN, with perioperative outcomes reported. Warm ischemia time and estimated blood loss were comparable between two groups, with overall operating time significantly longer for multifocal cohort.

102.

Haber GP, White WM, Crouzet S, White MA, Forest S, Autorino R, Kaouk JH. Robotic versus laparoscopic partial nephrectomy: single-surgeon matched cohort study of 150 patients. Urology. 2010;76:754–8.PubMedCrossRef

103.

Bhayani SB. Laparoscopic partial nephrectomy: fifty cases. J Endourol. 2008;22:313–6.PubMedCrossRef

104.

Simmons MN, Gill IS. Decreased complications of contemporary laparoscopic partial nephrectomy: use of a standardized reporting system. J Urol 2007;177:2067–2073; discussion 2073.

105.

Gill IS, Patil MB, Abreu AL, Ng C, Cai J, Berger A, et al. Zero ischemia anatomical partial nephrectomy: a novel approach. J Urol 2012.

106.

Tobis S, Knopf J, Silvers C, Yao J, Rashid H, Wu G, Golijanin D. Near infrared fluorescence imaging with robotic assisted laparoscopic partial nephrectomy: initial clinical experience for renal cortical tumors. J Urol. 2011;186:47–52.PubMedCrossRef

107.

Viprakasit DP, Altamar HO, Miller NL, Herrell SD. Selective renal parenchymal clamping in robotic partial nephrectomy: initial experience. Urology. 2010;76:750–3.PubMedCrossRef

Titel: The Role of Minimally Invasive Surgery in Multifocal Renal Cell Carcinoma
verfasst von: Serge Ginzburg
Robert G. Uzzo
Alexander Kutikov
Publikationsdatum: 01.06.2012
Verlag: Current Science Inc.
Erschienen in: Current Urology Reports / Ausgabe 3/2012
Print ISSN: 1527-2737
Elektronische ISSN: 1534-6285
DOI: https://doi.org/10.1007/s11934-012-0251-3

Neu im Fachgebiet Urologie

19.04.2024 | EAU 2024 | Kongressbericht | Nachrichten

Update Urologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

The Role of Minimally Invasive Surgery in Multifocal Renal Cell Carcinoma

Abstract

Neu im Fachgebiet Urologie

Varikozelen bei Jugendlichen: Das Für und Wider der Operation

Ureterstriktur: Innovative OP-Technik bewährt sich

Prostatakarzinom: EU initiiert neues Screeningkonzept

Blasenkarzinom – Biomarker statt Zytologie?

Update Urologie

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2012

Anterior Pelvic Organ Prolapse Repair Using Synthetic Mesh

Evaluation of Current Synthetic Mesh Materials in Pelvic Organ Prolapse Repair

Current Status of Robot-Assisted Laparoscopic Ureteral Reimplantation and Reconstruction

Central Compartment and Apical Defect Repair Using Synthetic Mesh

Evaluation of Current Biologic Meshes in Pelvic Organ Prolapse Repair

Stone Management for the Patient on Anticoagulation

Neu im Fachgebiet Urologie

Varikozelen bei Jugendlichen: Das Für und Wider der Operation

Ureterstriktur: Innovative OP-Technik bewährt sich

Prostatakarzinom: EU initiiert neues Screeningkonzept

Blasenkarzinom – Biomarker statt Zytologie?

Update Urologie